231 related articles for article (PubMed ID: 26478992)
1. Prion protein as a mediator of synaptic transmission.
Steinert JR
Commun Integr Biol; 2015; 8(4):e1063753. PubMed ID: 26478992
[TBL] [Abstract][Full Text] [Related]
2. Rab11 as a modulator of synaptic transmission.
Giorgini F; Steinert JR
Commun Integr Biol; 2013 Nov; 6(6):e26807. PubMed ID: 24563714
[TBL] [Abstract][Full Text] [Related]
3. Prion protein facilitates synaptic vesicle release by enhancing release probability.
Robinson SW; Nugent ML; Dinsdale D; Steinert JR
Hum Mol Genet; 2014 Sep; 23(17):4581-96. PubMed ID: 24722203
[TBL] [Abstract][Full Text] [Related]
4. Reversible symptoms and clearance of mutant prion protein in an inducible model of a genetic prion disease in Drosophila melanogaster.
Murali A; Maue RA; Dolph PJ
Neurobiol Dis; 2014 Jul; 67():71-8. PubMed ID: 24686303
[TBL] [Abstract][Full Text] [Related]
5. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Sträussler-Scheinker syndrome.
Gavin BA; Dolph MJ; Deleault NR; Geoghegan JC; Khurana V; Feany MB; Dolph PJ; Supattapone S
J Neurosci; 2006 Nov; 26(48):12408-14. PubMed ID: 17135402
[TBL] [Abstract][Full Text] [Related]
6. Transmissibility of Gerstmann-Sträussler-Scheinker syndrome in rodent models: New insights into the molecular underpinnings of prion infectivity.
Nonno R; Angelo Di Bari M; Agrimi U; Pirisinu L
Prion; 2016 Nov; 10(6):421-433. PubMed ID: 27892798
[TBL] [Abstract][Full Text] [Related]
7. Prion neurodegeneration: starts and stops at the synapse.
Mallucci GR
Prion; 2009; 3(4):195-201. PubMed ID: 19887910
[TBL] [Abstract][Full Text] [Related]
8. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease.
Caleo M; Restani L; Vannini E; Siskova Z; Al-Malki H; Morgan R; O'Connor V; Perry VH
PLoS One; 2012; 7(7):e41182. PubMed ID: 22815961
[TBL] [Abstract][Full Text] [Related]
9. Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease.
Rudge P; Jaunmuktane Z; Hyare H; Ellis M; Koltzenburg M; Collinge J; Brandner S; Mead S
Brain; 2019 Mar; 142(3):760-770. PubMed ID: 30698738
[TBL] [Abstract][Full Text] [Related]
10. [Genetic background of human prion diseases].
Kovács GG
Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
[TBL] [Abstract][Full Text] [Related]
11. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity.
Chiesa R; Restelli E; Comerio L; Del Gallo F; Imeri L
Prion; 2016 Mar; 10(2):93-102. PubMed ID: 26864450
[TBL] [Abstract][Full Text] [Related]
13. Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.
Pirisinu L; Di Bari MA; D'Agostino C; Marcon S; Riccardi G; Poleggi A; Cohen ML; Appleby BS; Gambetti P; Ghetti B; Agrimi U; Nonno R
Sci Rep; 2016 Feb; 6():20443. PubMed ID: 26841849
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
15. Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Sträussler-Scheinker.
Ghetti B; Piccardo P; Zanusso G
Handb Clin Neurol; 2018; 153():243-269. PubMed ID: 29887140
[TBL] [Abstract][Full Text] [Related]
16. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease.
Davies MJ; Cooper M; Perry VH; O'Connor V
Neurosci Lett; 2015 Mar; 589():138-43. PubMed ID: 25623034
[TBL] [Abstract][Full Text] [Related]
18. The prion diseases.
Brown K; Mastrianni JA
J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):277-98. PubMed ID: 20938044
[TBL] [Abstract][Full Text] [Related]
19. Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation.
Singh N; Zanusso G; Chen SG; Fujioka H; Richardson S; Gambetti P; Petersen RB
J Biol Chem; 1997 Nov; 272(45):28461-70. PubMed ID: 9353306
[TBL] [Abstract][Full Text] [Related]
20. Towards authentic transgenic mouse models of heritable PrP prion diseases.
Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
